Evaluating central oncology navigation and a new oncology research navigator for cancer care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study assesses the effectiveness of central oncology navigation (SOC) alone and in combination with an oncology research navigator (ORN) embedded in cancer care delivery. It involves two cohorts: one with patients newly diagnosed with genitourinary or thoracic cancers who have not yet experienced the central navigation program, and another with patients from gastrointestinal, hematology, and breast cancer clinics where the program is already implemented. Participants will be evaluated pre- and post-implementation to determine the impact of the navigation services on patient care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

* Informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
* Subject is willing and able to comply with study activities based on the judgement of the investigator.
* Age ≥ 18 years at the time of consent.
* Subject has a new patient appointment for cancer care at a UNC Medical Center and a confirmed cancer diagnosis.

Exclusion Criteria:

* Lack of internet access.
* Inability to understand the English language.
* Psychological or other disability resulting in the inability to provide informed consent.

Where it's running

• UNC Lineberger Comprehensive Cancer Center
  Chapel Hill, North Carolina, United States Recruiting

Study contacts

• Principal investigator: William A Wood, MD — UNC Lineberger Comprehensive Cancer Center
• Study coordinator: Mireille Leone
• Email: Mireille_Leone@med.unc.edu
• Phone: 919-445-0768

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adding targeted GRID-style radiation to standard palliative therapy for unresectable solid tumors

  This study tests whether adding spatially fractionated radiation therapy to standard palliative radiation helps relieve symptoms in patients with unresectable solid tumors.

  Recruiting at 2 sites Mayo Clinic · Scottsdale, Arizona and 1 other locations · NCT07856394

• First-in-human imaging of EphA2 using 68Ga-DOTA-EphA2 PET/CT

  This study tests a new 68Ga PET tracer designed to image EphA2 expression in adults with suspected or confirmed malignant tumors.

  Recruiting First Hospital of China Medical University · Shenyang, Liaoning · NCT07593209

• Irradiated tumor-and-stroma vaccine for advanced solid tumors

  This Phase 1 test will try an irradiated vaccine made from tumor cells and nearby stromal cells, with or without GM-CSF, to see if it is safe and can stimulate the immune system in people with advanced solid tumors.

  Recruiting Phase 1 West China Hospital · Chengdu, Sichuan and 1 other locations · NCT07567222

• Al18F‑NOTA‑FAPI PET imaging for cancer, cardiovascular, and autoimmune conditions

  This trial will test a new PET tracer called Al18F‑NOTA‑FAPI to image fibroblast activity in adults with cancer, heart disease, or autoimmune conditions and in healthy volunteers to see how safe and useful it is for guiding care.

  Recruiting Phase 1/2 Peking Union Medical College Hospital · Beijing · NCT07400224

• Psychological distress and its effects on treatment adherence, outcomes, and quality of life in people with cancer

  This study will try to see if anxiety and depression change how adults with cancer stick to treatment, their health outcomes, and their quality of life over three years.

  Recruiting First Affiliated Hospital of Wenzhou Medical University · Wenzhou, Zhejiang · NCT07193329

• Pre-treatment rehabilitation program for cancer patients

  This study is testing whether a special exercise and support program before cancer treatment can help high-risk patients feel better and have improved results during their care.

  Recruiting UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT06674889

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.